St. Jude Medical Announces FDA Approval of Epic Stented Tissue Valve with Anti-Calcification Technology (Business Wire via Yahoo! Finance)
ST. PAUL, Minn.----St. Jude Medical, Inc. today announced U.S. Food and Drug Administration approval of its Epic Stented Tissue Valve with Linx AC Technology. Identical in design to the company's Biocor Valve, which currently leads the tissue valve industry in U.S. market share growth, the Epic Valve also incorporates patented anti-calcification technology designed to protect against tissue ...

St. Jude Medical Announces FDA Approval Of Epic Stented Tissue Valve With Anti-Calcification Technology (Medical News Today)
St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) approval of its Epic(TM) Stented Tissue Valve with Linx(TM) AC Technology. Identical in design to the company's Biocor(TM) Valve, which currently leads the tissue valve industry in U.S. [click link for full article]